Activation of the MEK-S6 pathway in high-grade ovarian cancers.
Ventura AP, Radhakrishnan S, Green A, Rajaram SK, Allen AN, O'Briant K, Schummer M, Karlan B, Urban N, Tewari M, Drescher C, Knudsen BS.
Ventura AP, et al.
Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):499-508. doi: 10.1097/PAI.0b013e3181e53e1c.
Appl Immunohistochem Mol Morphol. 2010.
PMID: 20661131
Free PMC article.